Andrew Palm

Andrew Palm is Director of Integrated Process Analytics at Pfizer where he is a member of Analytical Research and Development in Groton, CT. Andrew has more than 22 years of pharmaceutical experience with the past 15 years focused on process analytical technology in both the small molecule API and drug product space. Currently, Andrew leads a team in Groton focused on PAT development and implementation to support API process development as well as a team in Ringaskiddy, Ireland which supports analytical testing and PAT for clinical manufacture. He also leads the Analytical Operations Team on Pfizer's API continuous manufacturing initiative, FAST, which includes system design, development and implementation of PAT and the Control Strategy. Previously, Andrew worked on Pfizer’s continuous drug product manufacturing initiative, PCMM, focusing on system integration, data engineering, validation and data integrity. Andrew is currently the Co-Chair of the ISPE PAT and LCS CoP Steering Team.